A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't ...

At the heart of innovation is T-win®, a groundbreaking vaccine platform that could change how we treat cancer.

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

OSE Immunotherapeutics has shared survival data behind a therapeutic vaccine’s phase 2 pancreatic cancer win as the French ...

Doctors are currently testing a vaccine for breast cancer they say can stop cancerous tumors from forming before they start.

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

I'm a clinical academic, which is quite a rare breed of doctor, because what I'm doing, along with other clinical academics, ...

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...

A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by ...